We. Communications study finds 88% of physicians change treatment due to health misinformation

• Waggener Edstrom Worldwide published a Sep. 10, 2026 health industry study on misinformation-driven prescribing risk for bio/pharma companies.
• Survey of 500 physicians in five countries found 88% changed treatment recommendations due to patient resistance rooted in false information.
• Physicians reported 35% of patients weekly require misinformation to be addressed before treatment; the figure rose to 48% in India.
• Expectations gap: 95% hold bio/pharma responsible for addressing misleading narratives; 35% rate companies very effective, a 60-point shortfall.
• Commercial impact signal: 79% would reduce prescribing if a company fails to address harmful narratives; 59% interpret silence as self-interest or complicity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Waggener Edstrom Worldwide Inc. published the original content used to generate this news brief on September 10, 2026, and is solely responsible for the information contained therein.